Nexalin Technology (NXL) News Today $1.01 +0.02 (+1.91%) As of 09:41 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NXL Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Nexalin and FatPipe Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TVMay 30, 2025 | usatoday.comNexalin Technology, Inc.: Strategic Advancements and Financial Stability Justify Buy RatingMay 29, 2025 | tipranks.comJoin Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on June 3May 28, 2025 | finance.yahoo.comJoin Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on June 3May 28, 2025 | globenewswire.comNexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer’s Program Amid Encouraging DataMay 13, 2025 | finance.yahoo.comNexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer's Program Amid Encouraging DataMay 13, 2025 | globenewswire.comNexalin Technology, Inc. Closes Public Offering of 3,850,000 Shares at $1.30 Per Share, Raising $5.0 MillionMay 6, 2025 | quiverquant.comQNexalin Technology Announces Closing of Previously Announced $5.0 Million Underwritten Public OfferingMay 6, 2025 | globenewswire.comNexalin Technology Announces Pricing of $5.0 Million Public Offering of Common StockMay 5, 2025 | globenewswire.comNexalin Technology Initiates FDA Q-Submission Process for Gen-2 SYNC Following Encouraging Data and Preliminary FDA FeedbackMay 1, 2025 | globenewswire.comNexalin Technology receives IRB approval in Brazil, begins trialApril 24, 2025 | markets.businessinsider.comNexalin Technology Receives IRB Approval in Brazil and Begins Clinical Trial for Anxiety and InsomniaApril 24, 2025 | globenewswire.comNexalin completes five phases of virtual clinic, digital research systemApril 24, 2025 | markets.businessinsider.comNexalin Technology files $50M common stock offeringApril 23, 2025 | msn.comNexalin Technology Announces Completion of Phases One Through Five of its Virtual Clinic and Digital Ecosystem for HALO™ Clinical Research and Patient ManagementApril 23, 2025 | globenewswire.comNexalin Technology expresses ‘strong support’ for Health Tech Investment ActApril 22, 2025 | markets.businessinsider.comNexalin Technology, Inc. Supports Health Tech Investment Act to Enhance Medicare Reimbursement for AI-Enabled Medical DevicesApril 21, 2025 | quiverquant.comQNexalin Technology Expresses Strong Support for Health Tech Investment Act to Advance Medicare Reimbursement for AI-Enabled DevicesApril 21, 2025 | globenewswire.comNexalin Technology Secures USPTO Patent for Deep Intracranial Frequency Stimulation (DIFS™) Technology in Treating Substance Use DisordersApril 14, 2025 | globenewswire.comNexalin enrolls first patients, advances toward treatment in UCSD trialApril 4, 2025 | markets.businessinsider.comNexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical TrialApril 2, 2025 | globenewswire.comJoin Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on April 3March 26, 2025 | markets.businessinsider.comJoin Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on April 3March 26, 2025 | globenewswire.comNexalin Technology upgraded to Buy from Hold at MaximMarch 25, 2025 | markets.businessinsider.comMaxim Group Upgrades Nexalin Technology (NXL)March 24, 2025 | msn.comNexalin Technology, Inc. (NASDAQ:NXL) VP Carolyn Hamby Shelton Buys 6,000 SharesMarch 14, 2025 | insidertrades.comNexalin receives a Notice of Allowance from USPTO for patent on DIFSMarch 4, 2025 | markets.businessinsider.comNexalin Technology Receives Notice of Allowance from the USPTO for Patent Covering Deep Intracranial Frequency Stimulation (DIFS™) Technology for Opioid and Other Substance Use DisordersMarch 3, 2025 | globenewswire.comNexalin Technology Announces Initiation of Patient Recruitment for UCSD’s TBI & PTSD Clinical Study Following IRB ApprovalMarch 1, 2025 | markets.businessinsider.comNexalin Technology announces initiation of patient recruitment in UCSD studyMarch 1, 2025 | markets.businessinsider.comNexalin Technology Announces Initiation of Patient Recruitment for UCSD's TBI & PTSD Clinical Study Following IRB ApprovalFebruary 28, 2025 | globenewswire.comNexalin Technology appoints Wesley Clark to Military, Government Advisory BoardFebruary 26, 2025 | markets.businessinsider.comNexalin Technology Welcomes General Wesley Clark to Military & Government Advisory BoardFebruary 26, 2025 | globenewswire.comNexalin Technology’s HALO Clarity headset approved for use in trials by UCSDFebruary 18, 2025 | markets.businessinsider.comNexalin Technology Announces UCSD IRB Approval for use of HALO™ Clarity in Clinical Trials for mTBI and PTSD TreatmentFebruary 18, 2025 | globenewswire.comNexalin appointed industry co-chair of National TBI Registry CoalitionFebruary 10, 2025 | markets.businessinsider.comNexalin Appointed as Industry Co-Chair of National TBI Registry CoalitionFebruary 10, 2025 | globenewswire.comNexalin Technology announces effective registration statementFebruary 6, 2025 | msn.comNexalin technology's chief medical officer buys $3,100 in sharesFebruary 5, 2025 | msn.comNexalin technology's chief medical officer buys $2,980 in common stockFebruary 5, 2025 | msn.comNexalin Technology announces publication of study of DIFS technologyFebruary 3, 2025 | markets.businessinsider.comNexalin Technology, Inc. Reports Landmark Study Highlights Efficacy of DIFS™ Technology in Reducing Blood Pressure in Patients with Major Depressive DisorderFebruary 3, 2025 | quiverquant.comQNexalin's Breakthrough DIFS™ Neurostimulation Device Demonstrates Reduction in Blood Pressure while Enhancing Mental Health According to New Landmark StudyFebruary 3, 2025 | globenewswire.comNexalin technology's chief medical officer buys $4,050 in stockJanuary 30, 2025 | msn.comNexalin technology's chief medical officer buys $7,700 in stockJanuary 24, 2025 | msn.comJoin Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session, Today, January 23January 23, 2025 | finance.yahoo.comJoin Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session, Today, January 23January 23, 2025 | globenewswire.comNexalin Technology, Inc.: Nexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025January 14, 2025 | finanznachrichten.deNexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025January 14, 2025 | markets.businessinsider.comNexalin Technology Completes Phase 1of its Innovative Virtual ClinicDecember 23, 2024 | globenewswire.com Get Nexalin Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for NXL and its competitors with MarketBeat's FREE daily newsletter. Email Address NXL Media Mentions By Week NXL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NXL News Sentiment▼1.890.94▲Average Business Services News Sentiment NXL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NXL Articles This Week▼11▲NXL Articles Average Week Get Nexalin Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for NXL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Hyperfine News Edap Tms News IceCure Medical News Milestone Scientific News Alpha Pro Tech News Carmell News Inovio Pharmaceuticals News Daxor News electroCore News Nephros News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NXL) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersRefund From 1933: Trump’s Reset May Create Instant WealthTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredThe Next Commodity Crisis Just Got a Name: SilverElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nexalin Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nexalin Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
